Google
ANIP — ANI PHARMACEUTICALS INC (Healthcare >> Drug Manufacturers - Specialty & Generic)
ANIP FAQ
What is ANIP's P/E ratio?
ANI PHARMACEUTICALS INC (ANIP) currently trades at a P/E ratio of 19.45.
What is ANIP's ROE?
ANI PHARMACEUTICALS INC reports a Return on Equity (ROE) of 15.95%.
What is ANIP's dividend yield?
ANI PHARMACEUTICALS INC offers a dividend yield of 0.00%.
What is ANIP's Deepscope Quality Score?
Deepscope rates ANIP's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy ANIP?
Deepscope's AI Timing Score for ANIP is 56 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does ANIP belong to?
ANI PHARMACEUTICALS INC is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange.
|
USD 74.65
Price
0.58
(0.78%)
Day Change
|
|
|---|
ANIP, ファンダメンタルスコアはnot good ( ファンダメンタル = 46) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEの伸びが低い
平均ROEが低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
47% |
| In Recommendations? | In "Invest - GROWTH" Section |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
1426
|
| Magic Formula Rank by ROE |
1426
|
| Magic Formula Rank by ROIC |
1153
|
| Price | 74.65 |
| PBV / Sector |
3.10 / 2.74
|
| Earning Per Share | 3.84 |
| PE / Sector |
19.45 / 23.29
|
| PEG or PE/Growth / Sector |
-0.07 / 0.11
|
| Average 1M Daily Value |
31.59 M
GREAT
|
| Average 1W Daily Value |
23.39 M
GREAT
|
| Timing Factors |
|
14% |
| Financial Health |
|
47% |
| ポイントになる統計 |
|
60% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-03 09:11:16 |
| Symbol | ANIP |
| Name | ANI PHARMACEUTICALS INC |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NASDAQ |
| Listed Shares | 22.73 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,743.97 / 9,635.82 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 210 Main Street West, Baudette, MN, United States, 56623
Phone: 218 634 3500
Website: https://www.anipharmaceuticals.com
Employees: 970
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
